MeSH term | MeSH ID | Detail |
---|---|---|
Edema | D004487 | 152 associated lipids |
Angina Pectoris | D000787 | 27 associated lipids |
Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
Total
3
Tribehenin is a lipid of Glycerolipids (GL) class.
We collected disease MeSH terms mapped to the references associated with Tribehenin
MeSH term | MeSH ID | Detail |
---|---|---|
Edema | D004487 | 152 associated lipids |
Angina Pectoris | D000787 | 27 associated lipids |
Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Butani D et al. | Topical Amphotericin B solid lipid nanoparticles: Design and development. | 2016 | Colloids Surf B Biointerfaces | pmid:26700229 |
Vithani K et al. | Sustained release solid lipid matrices processed by hot-melt extrusion (HME). | 2013 | Colloids Surf B Biointerfaces | pmid:23759381 |
Moazeni M et al. | Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. | 2016 | Colloids Surf B Biointerfaces | pmid:26974361 |
Patere SN et al. | Compritol®888 ATO a lipid excipient for sustained release of highly water soluble active: formulation, scale-up and IVIVC study. | 2013 | Curr Drug Deliv | pmid:23607649 |
Acevedo-Morantes CY et al. | Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells. | 2013 | Drug Deliv | pmid:24024505 |
Barakat NS et al. | Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. | 2009 | Drug Deliv | pmid:19555310 |
Hosny KM et al. | Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia. | 2015 | Drug Des Devel Ther | pmid:25609917 |
Wong PC et al. | A study on the solid state characteristics of spray-congealed glyceryl dibehenate solid lipid microparticles containing ibuprofen. | 2016 | Drug Dev Ind Pharm | pmid:26079425 |
Stanisz B et al. | Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. | 2013 | Drug Dev Ind Pharm | pmid:22348774 |
Punyamurthula NS et al. | Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol. | 2016 | Drug Dev Ind Pharm | pmid:26585693 |